Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study-Reference-Cited by-同舟云学术

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

Published:2017-08 Issue:8 Volume:17 Page:854-866
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Heppner D Gray,Kemp Tracy L,Martin Brian K,Ramsey William J,Nichols Richard,Dasen Emily J,Link Charles J,Das Rituparna,Xu Zhi Jin,Sheldon Eric A,Nowak Teresa A,Monath Thomas P,Heppner DG,Kemp TL,Martin BK,Ramsey WJ,Nichols R,Dasen EJ,Fusco J,Crowell J,Link C,Creager J,Monath TP,Das R,Xu ZJ,Klein R,Nowak T,Gerstenberger E,Bliss R,Sheldon EA,Feldman RA,Essink Brandon J,Smith WB,Chu L,Seger WM,Saleh J,Borders JL,Adams M

Funder

Biomedical Advanced Research and Development Authority

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Situation report—Ebola virus disease,2016

2. 2014–2015 West Africa Ebola crisis: impact update,2016

3. The cost of Ebola;Mullan;Lancet Glob Health,2015

4. On a path to accelerate access to Ebola vaccines: the WHO's research and development efforts during the 2014–2016 Ebola epidemic in West Africa;Henao-Restrepo;Curr Opin Virol,2016

5. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates;Mire;PLoS Negl Trop Dis,2012

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon;Journal of Infection;2024-10

2. Knowledge, attitudes, and practices and long-term immune response after rVSVΔG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda;Vaccine;2024-09

3. A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus;Frontiers in Immunology;2024-07-16

4. A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus;2024-05-31

5. Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics;2024-04-07